Key result
Patients with ACS and platelet disorders had significantly more marked abnormalities in platelet activation indicators, particularly platelet microparticles, compared to ACS patients with ASHD (p<0.01).
Why the study?
Are markers of chronic platelet activation elevated in patients with platelet disorders who develop acute coronary syndromes without significant atherosclerosis?
Case-Control (n=53)
Are markers of chronic platelet activation elevated in patients with platelet disorders who develop acute coronary syndromes without significant atherosclerosis?
p-value: p=<0.01
Chronic platelet activation may predispose patients with platelet disorders to acute coronary syndromes even in the absence of significant atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Supports chronic platelet activation predisposing to ACS in platelet disorders without atherosclerosis; hypothesis-generating, needs prospective validation before practice change.
Ozner et al. (1997) conducted a case-control in Acute coronary syndromes (n=53). Chronic platelet activation vs. ITP without ACS and ACS with atherosclerotic heart disease was evaluated on Platelet microparticles (PMP) and platelet-associated IgM (p=<0.01). Patients with ACS and platelet disorders had significantly more marked abnormalities in platelet activation indicators, particularly platelet microparticles, compared to ACS patients with ASHD (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: